Dajiang Wang

Dr. Dajiang Wang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2021 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
YLYing Liu
Ying Liu
YHYu Han
Yu Han
SCShizhu Chen
Shizhu Chen
JLJingjie Liu
Jingjie Liu
DWDajiang Wang
Dajiang Wang
YHYifei Huang
Yifei Huang
Photothermal therapy has the characteristics of minimal invasiveness, controllability, high efficiency, and strong specificity, which can effectively make up for the toxic side effects and tumor resistance caused by traditional drug treatment. However, due to the limited tissue penetration of infrared light, it is difficult to promote and apply in clinical practice. The eye is the only transparent tissue in human, and infrared light can easily penetrate the eye tissue, so it is expected that photothermal therapy can be used to treat fundus diseases. Here in, a new nano-platform assembled by liposome and indocyanine green (ICG) was used to treat retinoblastoma. ICG was assembled in liposomes to overcome some problems of ICG itself. For example, ICG is easily quenched, self-aggregating and instability. Moreover, liposomes can prevent free ICG from being cleared through the systemic circulation. The construction of the nano-platform not only ensured the stability of ICG in vivo, but also realized imaging-guide photothermal therapy, which created a new strategy for the treatment of retinoblastoma.

7 May 2020 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Closed access
PDF file
YLYing Liu
Ying Liu
JWJichen Wang
Jichen Wang
XJXin Jin
Xin Jin
ZXZhiyuan Xin
Zhiyuan Xin
XWXing Wu
Xing Wu
DWDajiang Wang
Dajiang Wang

8 November 2023 in Neural Regeneration Research
Verified
Journal Article
Open access
SWShaojun Wang
Shaojun Wang
STSiti Tong
Siti Tong
XJXin Jin
Xin Jin
NLNa Li
Na Li
PDPingxiu Dang
Pingxiu Dang
DWDajiang Wang
Dajiang Wang
JOURNAL/nrgr/04.03/01300535-202411000-00032/figure1/v/2026-06-18T063637Z/r/image-tiff High intraocular pressure causes retinal ganglion cell injury in primary and secondary glaucoma diseases, yet the molecular landscape characteristics of retinal cells under high intraocular pressure remain unknown. Rat models of acute hypertension ocular pressure were established by injection of cross-linked hyaluronic acid hydrogel (Healaflow®). Single-cell RNA sequencing was then used to describe the cellular composition and molecular profile of the retina following high intraocular pressure. Our results identified a total of 12 cell types, namely retinal pigment epithelial cells, rod-photoreceptor cells, bipolar cells, Müller cells, microglia, cone-photoreceptor cells, retinal ganglion cells, endothelial cells, retinal progenitor cells, oligodendrocytes, pericytes, and fibroblasts. The single-cell RNA sequencing analysis of the retina under acute high intraocular pressure revealed obvious changes in the proportions of various retinal cells, with ganglion cells decreased by 23%. Hematoxylin and eosin staining and TUNEL staining confirmed the damage to retinal ganglion cells under high intraocular pressure. We extracted data from retinal ganglion cells and analyzed the retinal ganglion cell cluster with the most distinct expression. We found upregulation of the B3gat2 gene, which is associated with neuronal migration and adhesion, and downregulation of the Tsc22d gene, which participates in inhibition of inflammation. This study is the first to reveal molecular changes and intercellular interactions in the retina under high intraocular pressure. These data contribute to understanding of the molecular mechanism of retinal injury induced by high intraocular pressure and will benefit the development of novel therapies.

9 July 2026 in Experimental Eye Research
Verified
Journal Article
Closed access
YSYang Sui
Yang Sui
STSiti Tong
Siti Tong
ZQZhe Qin
Zhe Qin
PDPingxiu Dang
Pingxiu Dang
TSTianyi Sui
Tianyi Sui
DWDajiang Wang
Dajiang Wang

24 September 2026 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
XHXiaolu Hao
Xiaolu Hao
DWDajiang Wang
Dajiang Wang
ZLZhaohui Li
Zhaohui Li
SWShaojun Wang
Shaojun Wang
Glaucoma is the leading cause of irreversible blindness worldwide, driven by progressive retinal ganglion cell (RGC) degeneration. While genetic and environmental risk factors have been identified, the cell-type-specific mechanisms underlying pathogenesis remain incompletely understood. Single-cell RNA sequencing (scRNA-seq) enables high-resolution analysis of cellular heterogeneity, developmental trajectories and intercellular communication networks. This review synthesizes recent scRNA-seq advances across two critical domains in glaucoma research: (1) aqueous humor outflow pathway (AHOP) physiology and pathology; (2) primary open-angle glaucoma (POAG) pathogenesis. We identify convergent themes, including mitochondrial dysfunction as a shared mechanism across subtypes, the central role of neuroinflammation in RGC degeneration, and the therapeutic potential of metabolic interventions. We further discuss challenges in translating animal models to human disease, integrating multi-species datasets, and resolving cell-type-specific susceptibility. Finally, we highlight emerging directions in spatial transcriptomics, multi-omics integration, and precision medicine.